ASPIRO is the first multi-patient, multi-center clinical trial of an autologous cell therapy for Parkinson's disease. It is evaluating safety, tolerability, and preliminary efficacy of ANPD001 in ...

As we head into 2026, continuous education around the nuances and misconceptions of AI will support process industries—and ...

As organizations consider the synergy of digital twins and RTLS for factory optimization, having a clear understanding of ...

The partnership aims to combine AI infrastructure, simulation, and industrial expertise to create AI-driven manufacturing and ...

Fictiv combines AI tools with precision welding and assembly to cut prototype-to-production time for complex manufacturing ...